Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Anesthesiology. 2022 Nov 1;137(5):620–643. doi: 10.1097/ALN.0000000000004338

Table 2:

(A) Ocular complications in non-ocular surgery, risk factors, prevention, and treatment. (B) Commonly encountered ocular conditions, pre- and intra-operative concerns, what is known/not known in relation to anesthesia, and management recommendations. See text for more details and references. Due to space constraints, not all conditions are shown.

A Exposure keratopathy Loss of eye contents Acute angle closure glaucoma Ischemic optic neuropathy Central retinal artery occlusion
Risk Factors *General anesthesia
*Decreased tear production
*Patient positioning
*Abnormal eyelid closure
*Corneal transplant
*Open globe injury
*History of glaucoma
*Genetics
*Female
*Elderly
*Anatomical factors
*Asian race
*Spine fusion
*Cardiac surgery
*Head and neck
*For spine surgery: Prone positioning, large estimated blood losses, lower colloid compared to crystalloid fluid administration, lengthier anesthesia duration, Wilson frame use, obesity, and male sex
*Spine fusion
*Cardiac surgery
*Head and neck
*Use of N2O with recent vitrectomy and gas bubble
*For spine surgery: compression of the eye
*For cardiac surgery: emoblism from heart or aorta
Prevention *Completely cover the eyes after induction of anesthesia
*Use of ointments in some cases
*Remove contact lenses
*Protect eye from false eyelashes
*Protect eyes from trauma/increased IOP
*Eye shield, caution during positioning of patient
*Medications to avoid in susceptible individuals (see text): para-sympatholytic or sympathomimetic drugs No established strategy but see text for ASA Task Force on Perioperative Visual Loss recommendations *Headrests and care to prevent eye compression in spine surgery with patient prone
*Decrease embolic phenomena in heart surgery
*Avoid N2O when vitreous gas bubble present (see text)
Treatment *Analgesia (local anesthetic eye drops not advisable)
*Antibiotics/eye cover in some cases
*Treatment/followup by an ophthalmologist
*None. Prevention is paramount to avoid profound visual loss * Immediate reduction of IOP by medications AND
*Peripheral iridectomy
*Treatment/followup by an ophthalmologist
*Increase blood pressure and hemoglobin levels *Elevate the head *Steroids
*Hyperbaric oxygen
None of these are proven effective.
In all cases, consultation on treatment with neuro-ophthalmologist
*Thrombolysis, but may be risky in post-operative patient.
*Consultation on treatment with neuro-ophthalmologist
B Idiopathic intracranial hypertension Glaucoma Low vision
Pre-op eye concerns *Optic nerve disease: double vision, loss of vision, optic nerve swelling *Visual field loss, low vision, increased intraocular pressure *Difficulty with consent
*Communication issues
*Altered mood, alertness
Intra-operative concerns *Spinal and epidural analgesia
*Caution in COPD patients on acetazolamide
*Head down or prone positioning and visual outcomes *None
What is known *Both spinal and epidural may be used safely
*Continue pre-operative medications for the disease
*Intraocular pressure increased by positioning prone or head down *Many causes including glaucoma, diabetic retinopathy, macular degeneration, congenital
What is not known/Perioperative management recommendations *Impact of further increases in intraocular pressure on vision after surgery/positioning prone or head down is not known
*Advisable to keep systemic blood pressure at or near patient’s baseline, as systemic blood pressure is a major influence on ocular perfusion pressure; evidence base still lacking.
*Continue the patient’s pre-operative eye drops up until time of surgery
*The impact of low vision with or without altered alertness on awakening after anesthesia is not known.
*Anticipate the need for more time to obtain a pre-operative anesthesia consent.

Abbreviations: ASA = American Society of Anesthesiologists. COPD = chronic obstructive pulmonary disease. IOP = intraocular pressure. N2O = nitrous oxide